The article you requested is
Lack of Desipramine Toxicity With Citalopram
J Clin Psychiatry 2000;61:145-145 [letter]
Copyright 2000 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $40
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP print + online for $166 individual.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
Letter to the Editor
Sir: Selective serotonin reuptake inhibitors (SSRIs) are
known to inhibit specific human hepatic cytochrome P450
(CYP) isoenzymes, which are critical in the metabolism of most
medications. Paroxetine is thought to possess highly potent
inhibiting properties for the CYP2D6 isoenzyme. CYP2D6 is
the major enzyme involved in catabolism of many commonly
used agents, including neuroleptics, antidepressants, Type IC
antiarrhythmics, codeine, ß-blockers, and dextromethorphan.